Deal represents part of Boehringer Ingelheim’s strategy to provide breakthrough cancer therapies
News
New life sciences development destined for Paddington
The sites will maximise local and global benefits of NHS, research, industry and community partnerships
New revelations from monkeypox outbreak study
Unique skin symptoms of the current monkeypox outbreak include pseudo-pustules
Dexcom ONE glucose monitoring system available on prescription
System improves management for people with diabetes by offering finger prick-free monitoring
Ipsen and Marengo Therapeutics announce strategic partnership
Deal will advance precision immuno-oncology candidates from Marengo’s STAR platform
Cyclerion reveals data for schizophrenia therapy
Study data demonstrates positive effects of CY6463 on cognition and inflammation
Tallac announces first patient treated with TAC-001
The phase 1/2 study is for patients with advanced or metastatic solid tumours
CNX embarks on buy-and-build strategy
Investment is a key boost to the acceleration of treatment access in the UK
Scientists to rewrite DNA in search for heart disease cure
The British Heart Foundation’s ‘Big Beat Challenge’ grant of £30m for research into cardiovascular medicine was given to CureHeart
Novartis’ Beovu recommended by NICE
Patients set to benefit from new treatment for sight-threatening eye condition
Roche testing to help diagnose pre-eclampsia receives NICE recommendation
Predicting which women are likely to develop pre-eclampsia will help clinicians to decide on the most appropriate care
Chiesi reinforces commitment to reducing emissions
First carbon minimal pMDI is on track with the joint goal of benefitting patients and the planet
Iconovo receives $883,800 grant from the Bill & Melinda Gates Foundation
Funding will develop inhaled therapies using ICOone Nasal in preparation for the next pandemic
MHRA grants marketing authorisation for Global Blood Therapeutics’s Oxbryta
Voxelotor is the first medicine in Britain to directly inhibit sickle haemoglobin polymerisation
Aurinia receives positive CHMP opinion for Lupkynis
Therapy effectively treats adults with active lupus nephritis in Europe
